Summit Wealth Group’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$318K	Buy	323,000 +30,000	+10%	+$29.5K	0.08%	81
2025 Q1	$422K	Buy	293,000 +136,000	+87%	+$196K	0.12%	63
2024 Q4	$345K	Buy	157,000 +117,000	+293%	+$257K	0.1%	69
2024 Q3	$66K	Buy	+40,000	New	+$66K	0.02%	98